Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit nuclear factor-κB activity and synergize with bortezomib and ibrutinib in hematologic cancers

Chronic lymphocytic leukemia (CLL) and multiple myeloma are incurable hematologic malignancies that are pathologically linked with aberrant nuclear factor-kappa B (NF-κB) activation. In this study, we identified a group of novel C8-linked benzofused pyrrolo[2,1- c][1,4]benzodiazepine monomeric hybri...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Thomas, Corcoran, David B., Thurston, David E., Giles, Peter J., Ashelford, Kevin, Walsby, Elisabeth J., Fegan, Christopher D., Pepper, Andrea G. S., Rahman, Khondaker Miraz, Pepper, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018133/
https://www.ncbi.nlm.nih.gov/pubmed/32381576
http://dx.doi.org/10.3324/haematol.2019.238584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018133/
https://www.ncbi.nlm.nih.gov/pubmed/32381576
http://dx.doi.org/10.3324/haematol.2019.238584

Ejemplares similares